We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. Show more
Realigning resources to extend runway to mid-2027 Focus on clinical development of RP-1664 (PLK4 inhibitor) and RP-3467 (PolΞΈ ATPase inhibitor), with initial clinical readouts expected beginning...
Heavily-pretreated patients on lunresertib and camonsertib combination achieved 25.9% overall response rate (ORR) in endometrial cancer and 37.5% in platinum-resistant ovarian cancer Nearly half...
Event to be webcast live on Thursday, December 12 at 4:30 p.m. ET Repare Therapeutics Inc. (βRepareβ or the βCompanyβ) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today...
Repare Therapeutics Inc. (βRepareβ or the βCompanyβ) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a Cooperative Research and Development Agreement (CRADA...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.04 | 2.98507462687 | 1.34 | 1.48 | 1.25 | 520595 | 1.35692601 | CS |
4 | -0.8901 | -39.2097264438 | 2.2701 | 2.4 | 1.2 | 872986 | 1.48047544 | CS |
12 | -1.97 | -58.8059701493 | 3.35 | 4.0695 | 1.2 | 393485 | 2.1217764 | CS |
26 | -2.04 | -59.649122807 | 3.42 | 4.29 | 1.2 | 239364 | 2.47161196 | CS |
52 | -5.93 | -81.121751026 | 7.31 | 8.49 | 1.2 | 218085 | 3.44523348 | CS |
156 | -15.02 | -91.5853658537 | 16.4 | 18.68 | 1.2 | 247948 | 9.03770836 | CS |
260 | -30.67 | -95.6942277691 | 32.05 | 46.44 | 1.2 | 215070 | 13.97781966 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions